Welcome to our dedicated page for Sintx Technologies news (Ticker: SINT), a resource for investors and traders seeking the latest updates and insights on Sintx Technologies stock.
SINTX Technologies, Inc. (NASDAQ: SINT) is an advanced ceramics and biomaterials company headquartered in Salt Lake City, Utah, with news flow centered on silicon nitride–based medical technologies, implant systems, and infection‑prevention platforms. This news page aggregates company press releases and third‑party coverage so readers can follow developments in its silicon nitride biomaterials, polymer composites, and antipathogenic fabric technologies.
Recent SINTX news highlights regulatory milestones and product launches, including U.S. FDA 510(k) clearance for the SINAPTIC Foot & Ankle Osteotomy Wedge System and the launch of OsseoSculpt, a biologic designed to complement the SINAPTIC wedge portfolio. Updates also cover the company’s focused commercialization plan around infection‑resistant silicon nitride devices and polymer composites, as well as early product revenue from OsseoSculpt.
Investors and industry observers will find coverage of strategic agreements, such as the supply agreement with EVONIK to manufacture SINTX’s proprietary SiN/PEEK compound for AI‑assisted, 3D‑printed, patient‑specific implants. News items also track SINTX’s intellectual‑property progress, including Notices of Allowance from the United States Patent and Trademark Office for composition and method patents covering antipathogenic fibrous materials and fabric technologies.
In addition, SINTX issues releases on capital markets activity and corporate events, including warrant exercises, at‑the‑market offering arrangements, and participation in investor conferences hosted by firms such as H.C. Wainwright and Sidoti & Company. These updates provide context on the company’s financing strategy and investor outreach.
By monitoring this page, readers can review SINTX news related to medical device clearances, biologic product introductions, infection‑prevention patents, financing transactions, and investor presentations, all in one place.
SINTX Technologies announced a 1-for-200 reverse stock split effective May 28, 2024, aimed at meeting Nasdaq's minimum bid requirements. The split will reduce outstanding shares from 123 million to 0.6 million while maintaining stockholder percentage interest. Existing shares will be automatically converted, and the company will start trading on a split-adjusted basis under the symbol 'SINT' from the effective date. No cash will be provided for fractional shares, which will be rounded up. The transfer agent will update stockholders' accounts accordingly.
SINTX Technologies, Inc. and Prodways Printers SAS have formed a technical partnership and ceramic slurry supply agreement. SINTX will supply ceramic-filled slurries to Prodways for 3D printing applications. SINTX is known for its expertise in 3D printing ceramics and has a history of successful component production. The partnership will enable collaboration on advanced technical ceramics, particularly in casting applications. Prodways will utilize SINTX's qualified slurries on their latest MovingLight machines, enhancing their capabilities in ceramic printing.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.